News & Analysis on Clinical Trial Services & Contract Research And Development
Caliper Life Sciences has launched its latest addition to the company's suite of in vivo imaging systems promising advanced fluorescent detection capability for accelerating the drug discovery and development process reducing cost and time in the...
The battle for the acquisition that will form the world's third biggest generic drugmaker has intensified, with Iceland's Actavis making a new offer for Croatian drug manufacturer Pliva that surpasses that of US pharmaceutical firm Barr by $200m (€156m).
Drug giant Pfizer is claiming victory in defending the world's most prescribed branded medicine for treating hypertension after a US court ruled that Dutch drugmaker Synthon's generic copy of Norvasc (amlodipine besylate) infringed upon a US patent...
TNS Healthcare has scooped up a new deal with Pfizer to provide the drug giant's UK arm with sales and market information in order to help them achieve their sales objectives.
In an attempt to counter competition in generic active pharmaceutical ingredients (APIs) from Asian manufacturers, BASF has decided to downscale production at its Minden production site, implementing a restructuring programme that includes the...